2008-002063-13
Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Pfizer Inc·EU Clinical Trials Register
Study focus
- Disease/Condition
- Major Depressive Disorder
Sponsor & location
- Primary sponsor
- Pfizer Inc
- Funder
- Pfizer, Inc.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Change from Baseline to Week 8 visit in the CDRS-R total score
ICD-10 classifications
Recurrent depressive disorderRecurrent depressive disorder, unspecifiedDepressive conduct disorderOther recurrent depressive disordersRecurrent depressive disorder, current episode moderate
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2008-002063-13
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2008-002063-13 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc and is currently status unknown. The study focuses on Major Depressive Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.